Novigenix Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.96M
- Investors
-
4
Novigenix General Information
Description
Developer of a precision medicine platform designed for the detection of disease, therapy optimization, and disease recurrence monitoring. The company's platform is optimized for mapping the immune system's response to the onset and progression of the disease by integrating patient multi-omics data, advanced machine learning, and artificial intelligence (AI) approaches, providing medical professionals with actionable insights and precision tools for optimizing patients' therapeutic journeys.
Contact Information
Website
www.novigenix.comCorporate Office
- Route de la Corniche 3
- Phenyl Building, Biopôle IV
- 1066 Epalinges
- Switzerland
Corporate Office
- Route de la Corniche 3
- Phenyl Building, Biopôle IV
- 1066 Epalinges
- Switzerland
Novigenix Timeline
Novigenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 09-Apr-2025 | $1.96M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 18-Feb-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 15-Nov-2022 | $20M | $20M | Completed | Generating Revenue | |
| 1. Grant | 21-Jan-2021 | $1.22M | Completed | Startup |
Novigenix Comparisons
Industry
Financing
Details
Novigenix Competitors (26)
One of Novigenix’s 26 competitors is Congenica, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Congenica | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Superfluid DX | Venture Capital-Backed | South San Francisco, CA | ||||
| Freenome | Formerly VC-backed | Brisbane, CA | ||||
| Boreal Genomics | Formerly VC-backed | Vancouver, Canada | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL |
Novigenix Patents
Novigenix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4782555-A1 | Methods for analysing and predicting response to a immune checkpoint blockade therapy | Pending | 27-Jan-2025 | ||
| WO-2026159317-A1 | Methods for analysing and predicting response to a immune checkpoint blockade therapy | Pending | 27-Jan-2025 | ||
| EP-4584399-A1 | Methods to predict response to icbt of a patient having cancer | Pending | 07-Sep-2022 | ||
| US-20260071280-A1 | Methods to predict response to icbt of a patient having cancer | Pending | 07-Sep-2022 | ||
| WO-2024052233-A9 | Methods to predict response to icbt of a patient having cancer | Inactive | 07-Sep-2022 | C12Q1/6886 |
Novigenix Signals
Novigenix Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovative Medicines Initiative | Government | |||
| Microsoft for Startups | Accelerator/Incubator | |||
| Matwin | Accelerator/Incubator | |||
| Eurostars | Other |
Novigenix Acquisitions (1)
Novigenix’s most recent deal was a Merger/Acquisition with Diagnoplex. The deal was made on 12-Feb-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Diagnoplex | 12-Feb-2015 | Merger/Acquisition | Laboratory Services (Healthcare) |
Novigenix FAQs
-
When was Novigenix founded?
Novigenix was founded in 2014.
-
Where is Novigenix headquartered?
Novigenix is headquartered in Epalinges, Switzerland.
-
What is the size of Novigenix?
Novigenix has 19 total employees.
-
What industry is Novigenix in?
Novigenix’s primary industry is Decision/Risk Analysis.
-
Is Novigenix a private or public company?
Novigenix is a Private company.
-
What is Novigenix’s current revenue?
The current revenue for Novigenix is .
-
How much funding has Novigenix raised over time?
Novigenix has raised $20M.
-
Who are Novigenix’s investors?
Innovative Medicines Initiative, Microsoft for Startups, Matwin, and Eurostars have invested in Novigenix.
-
Who are Novigenix’s competitors?
Congenica, Superfluid DX, Freenome, Boreal Genomics, and Tempus AI are some of the 26 competitors of Novigenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process